Liquidia LQDA Stock
Liquidia Price Chart
Liquidia LQDA Financial and Trading Overview
| Liquidia stock price | 32.1 USD |
| Previous Close | 14.6 USD |
| Open | 14.7 USD |
| Bid | 14.5 USD x 400 |
| Ask | 18.4 USD x 200 |
| Day's Range | 14.25 - 14.96 USD |
| 52 Week Range | 8.26 - 19.41 USD |
| Volume | 1.77M USD |
| Avg. Volume | 2.2M USD |
| Market Cap | 1.24B USD |
| Beta (5Y Monthly) | 0.043 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.46 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 30.3 USD |
LQDA Valuation Measures
| Enterprise Value | 1.04B USD |
| Trailing P/E | N/A |
| Forward P/E | -9.320513 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 87.87786 |
| Price/Book (mrq) | 24.939966 |
| Enterprise Value/Revenue | 73.745 |
| Enterprise Value/EBITDA | -8.255 |
Trading Information
Liquidia Stock Price History
| Beta (5Y Monthly) | 0.043 |
| 52-Week Change | 27.99% |
| S&P500 52-Week Change | 13.16% |
| 52 Week High | 19.41 USD |
| 52 Week Low | 8.26 USD |
| 50-Day Moving Average | 14.96 USD |
| 200-Day Moving Average | 13.39 USD |
LQDA Share Statistics
| Avg. Volume (3 month) | 2.2M USD |
| Avg. Daily Volume (10-Days) | 2.09M USD |
| Shares Outstanding | 85.48M |
| Float | 66.18M |
| Short Ratio | 6.69 |
| % Held by Insiders | 13.64% |
| % Held by Institutions | 65.04% |
| Shares Short | 19.5M |
| Short % of Float | 28.41% |
| Short % of Shares Outstanding | 22.82% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2024 |
| Most Recent Quarter (mrq) | March 31, 2025 |
| Next Fiscal Year End | December 31, 2025 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1135.41% |
| Gross Margin | 58.08% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -37.66% |
| Return on Equity (ttm) | -203.97% |
Income Statement
| Revenue (ttm) | 14.14M USD |
| Revenue Per Share (ttm) | 0.17 USD |
| Quarterly Revenue Growth (yoy) | 5.00% |
| Gross Profit (ttm) | 8.22M USD |
| EBITDA | -126359000 USD |
| Net Income Avi to Common (ttm) | -138678000 USD |
| Diluted EPS (ttm) | -1.71 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 169.76M USD |
| Total Cash Per Share (mrq) | 1.99 USD |
| Total Debt (mrq) | 147.66M USD |
| Total Debt/Equity (mrq) | 297.04 USD |
| Current Ratio (mrq) | 2.928 |
| Book Value Per Share (mrq) | 0.583 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -99235000 USD |
| Levered Free Cash Flow (ttm) | -64382000 USD |
Profile of Liquidia
| Country | United States |
| State | NC |
| City | Morrisville |
| Address | 419 Davis Drive |
| ZIP | 27560 |
| Phone | 919 328 4400 |
| Website | https://www.liquidia.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 170 |
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneous infusion; and develops L606, an investigational liposomal formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company has a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD. Liquidia Corporation was founded in 2004 and is based in Morrisville, North Carolina.
Q&A For Liquidia Stock
What is a current LQDA stock price?
Liquidia LQDA stock price today per share is 32.1 USD.
How to purchase Liquidia stock?
You can buy LQDA shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Liquidia?
The stock symbol or ticker of Liquidia is LQDA.
Which industry does the Liquidia company belong to?
The Liquidia industry is Biotechnology.
How many shares does Liquidia have in circulation?
The max supply of Liquidia shares is 87M.
What is Liquidia Price to Earnings Ratio (PE Ratio)?
Liquidia PE Ratio is now.
What was Liquidia earnings per share over the trailing 12 months (TTM)?
Liquidia EPS is -1.46 USD over the trailing 12 months.
Which sector does the Liquidia company belong to?
The Liquidia sector is Healthcare.
Liquidia LQDA included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 22984.54 USD — |
+0.49
|
5.85B USD — | 22587.11 USD — | 22992.32 USD — | — - | 5.85B USD — |
| US Tech Capital Market Composite RCMP | 123.15 USD — |
+1.01
|
— — | 120.68 USD — | 123.19 USD — | — - | — — |
| US Tech Health Care IXHC | 1201.08 USD — |
+1.22
|
— — | 1188.53 USD — | 1201.91 USD — | — - | — — |
- {{ link.label }} {{link}}